(Q41167388)

English

Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy

scientific article published on 12 September 2012

Statements

Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy (English)
Juan Antonio Palacios
Teresa Pérez-Piñar
Beatriz Sanz-Minguela
Victoria Moreno
Eulalia Valencia
César Gómez-Hernando
Berta Rodés
12 September 2012
13081-13084

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit